Florida Cancer Specialists Lead the Way in Enhanced Oncology Care with Innovative Practices

Enhancing Oncology Care: Florida Cancer Specialists at NCODA Spring Forum



Florida Cancer Specialists & Research Institute, LLC (FCS) is making significant strides in the realm of oncology care by sharing their expertise at the NCODA 2025 International Spring Forum in Denver, a premier event that focuses on improving patient-centered care in cancer treatment. With their extensive background in pharmacy services integrated within oncology, FCS is positioned as a leader in the field, driving positive outcomes for patients through effective medication management and operational excellence.

During the forum, FCS leaders are set to present their insights on specialty pharmacy operations, which encompasses patient navigation, dispensing best practices, and the crucial role these elements play in enhancing patient experiences. Dr. Lucio N. Gordan, President and Managing Physician of FCS, emphasized the importance of these discussions, stating, “We welcome this opportunity to join our clinical and industry colleagues and share top-tier knowledge that is advancing patient-centered cancer treatment throughout the entire care continuum.” Notably, Dr. Gordan's involvement extends to his recent appointment to NCODA's board of directors, highlighting FCS's commitment to leading advancements in cancer care.

FCS's innovative pharmacy, Rx To Go, has become a vital component of their patient care model, providing personalized support, timely medication access, and educational resources for effective drug usage. The pharmacy is focused on delivering efficient and convenient home delivery of oral oncolytic medications, which represent a growing segment of cancer treatment protocols. As noted by Paul Chadwick, Chief Value & Procurement Officer at FCS, “Through collaborative integration, we are positively enhancing the patient experience and contributing to positive clinical outcomes.” This approach underscores FCS's dedication to not only meeting patient needs but exceeding them through comprehensive care services.

At the NCODA Spring Forum, several workshops and discussions are planned. Key FCS representatives, including Chris Elder, PharmD, BCOP, and Danielle Brown, MBA, BSN, RN, OCN, will guide discussions around crucial topics such as enhancing patient navigation and practical strategies for transforming oncology care. These sessions are designed to focus on real-world applications and evidence-based practices, aimed at improving overall patient outcomes in oncology settings.

FCS also champions the integration of clinical research within their practices, emphasizing access to clinical trials, which is instrumental in pioneering the availability of breakthrough cancer therapies. As one of the foremost entities for clinical research in Florida, FCS ensures that patients can participate in trials that often serve as an initial testing ground for emerging cancer medications before they receive FDA approval. This dedication to research reflects their commitment to delivering state-of-the-art cancer treatments to their patients.

In conclusion, Florida Cancer Specialists & Research Institute is not only at the forefront of oncological care but also actively shaping the future of cancer treatment through innovative practices and community collaboration. Their presence at the NCODA Spring Forum exemplifies their ongoing mission to ensure that cancer treatment remains both patient-centered and advanced, providing high-quality care that truly makes a difference in the lives of patients battling cancer.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.